102 related articles for article (PubMed ID: 28042713)
1. CLarifying vaginal atrophy's impact On SEx and Relationships (CLOSER) survey in South Africa.
Guidozzi F; Thomas C; Smith T; Nappi RE
Climacteric; 2017 Feb; 20(1):49-54. PubMed ID: 28042713
[TBL] [Abstract][Full Text] [Related]
2. Clarifying Vaginal Atrophy's Impact on Sex and Relationships (CLOSER) survey: emotional and physical impact of vaginal discomfort on North American postmenopausal women and their partners.
Simon JA; Nappi RE; Kingsberg SA; Maamari R; Brown V
Menopause; 2014 Feb; 21(2):137-42. PubMed ID: 23736862
[TBL] [Abstract][Full Text] [Related]
3. The CLOSER (CLarifying Vaginal Atrophy's Impact On SEx and Relationships) survey: implications of vaginal discomfort in postmenopausal women and in male partners.
Nappi RE; Kingsberg S; Maamari R; Simon J
J Sex Med; 2013 Sep; 10(9):2232-41. PubMed ID: 23809691
[TBL] [Abstract][Full Text] [Related]
4. The CLOSER survey: impact of postmenopausal vaginal discomfort on women and male partners in the UK.
Domoney C; Currie H; Panay N; Maamari R; Nappi RE
Menopause Int; 2013 Jun; 19(2):69-76. PubMed ID: 23778561
[TBL] [Abstract][Full Text] [Related]
5. The CLOSER survey: impact of postmenopausal vaginal discomfort on relationships between women and their partners in Northern and Southern Europe.
Nappi RE; Mattsson LÅ; Lachowsky M; Maamari R; Giraldi A
Maturitas; 2013 Aug; 75(4):373-9. PubMed ID: 23731983
[TBL] [Abstract][Full Text] [Related]
6. Vulvar and vaginal atrophy as viewed by the Spanish REVIVE participants: symptoms, management and treatment perceptions.
Palacios S; Cancelo MJ; Castelo Branco C; Llaneza P; Molero F; Borrego RS
Climacteric; 2017 Feb; 20(1):55-61. PubMed ID: 28042734
[TBL] [Abstract][Full Text] [Related]
7. Impact of postmenopausal vaginal discomfort on sex and relationships in Brazil: the CLOSER survey.
Pompei LM; Wender MCO; Kulak J; Pires I; Suvarna Y; Nappi RE
Climacteric; 2021 Dec; 24(6):593-599. PubMed ID: 33899627
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of postmenopausal symptoms in North America and Europe.
Minkin MJ; Reiter S; Maamari R
Menopause; 2015 Nov; 22(11):1231-8. PubMed ID: 25944521
[TBL] [Abstract][Full Text] [Related]
9. The Women's EMPOWER Survey: Women's Knowledge and Awareness of Treatment Options for Vulvar and Vaginal Atrophy Remains Inadequate.
Krychman M; Graham S; Bernick B; Mirkin S; Kingsberg SA
J Sex Med; 2017 Mar; 14(3):425-433. PubMed ID: 28202319
[TBL] [Abstract][Full Text] [Related]
10. Vulvar and vaginal atrophy in four European countries: evidence from the European REVIVE Survey.
Nappi RE; Palacios S; Panay N; Particco M; Krychman ML
Climacteric; 2016 Apr; 19(2):188-97. PubMed ID: 26581580
[TBL] [Abstract][Full Text] [Related]
11. Perceptions of dyspareunia in postmenopausal women with vulvar and vaginal atrophy: findings from the REVIVE survey.
Freedman MA
Womens Health (Lond); 2014 Jul; 10(4):445-54. PubMed ID: 25259904
[TBL] [Abstract][Full Text] [Related]
12. Vaginal Health: Insights, Views & Attitudes (VIVA-LATAM): results from a survey in Latin America.
Nappi RE; de Melo NR; Martino M; Celis-González C; Villaseca P; Röhrich S; Palacios S
Climacteric; 2018 Aug; 21(4):397-403. PubMed ID: 29741110
[TBL] [Abstract][Full Text] [Related]
13. Quality of life and sexual function of naturally postmenopausal women on an ultralow-concentration estriol vaginal gel.
Caruso S; Cianci S; Amore FF; Ventura B; Bambili E; Spadola S; Cianci A
Menopause; 2016 Jan; 23(1):47-54. PubMed ID: 26079974
[TBL] [Abstract][Full Text] [Related]
14. Technological evolution in the radiofrequency treatment of vaginal laxity and menopausal vulvo-vaginal atrophy and other genitourinary symptoms: first experiences with a novel dynamic quadripolar device.
Vicariotto F; Raichi M
Minerva Ginecol; 2016 Jun; 68(3):225-36. PubMed ID: 27206062
[TBL] [Abstract][Full Text] [Related]
15. Vaginal health in the United States: results from the Vaginal Health: Insights, Views & Attitudes survey.
Simon JA; Kokot-Kierepa M; Goldstein J; Nappi RE
Menopause; 2013 Oct; 20(10):1043-8. PubMed ID: 23571518
[TBL] [Abstract][Full Text] [Related]
16. Vulvovaginal symptoms prevalence in postmenopausal women and relationship to other menopausal symptoms and pelvic floor disorders.
Erekson EA; Li FY; Martin DK; Fried TR
Menopause; 2016 Apr; 23(4):368-75. PubMed ID: 26645820
[TBL] [Abstract][Full Text] [Related]
17. Predictors of impact of vaginal symptoms in postmenopausal women.
Hunter MM; Nakagawa S; Van Den Eeden SK; Kuppermann M; Huang AJ
Menopause; 2016 Jan; 23(1):40-6. PubMed ID: 26173074
[TBL] [Abstract][Full Text] [Related]
18. Biopsychosocial predictors of postmenopausal dyspareunia: the role of steroid hormones, vulvovaginal atrophy, cognitive-emotional factors, and dyadic adjustment.
Kao A; Binik YM; Amsel R; Funaro D; Leroux N; Khalifé S
J Sex Med; 2012 Aug; 9(8):2066-76. PubMed ID: 22621792
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and impact of vaginal symptoms among postmenopausal women.
Santoro N; Komi J
J Sex Med; 2009 Aug; 6(8):2133-42. PubMed ID: 19493278
[TBL] [Abstract][Full Text] [Related]
20. The Association Between Vulvovaginal Atrophy Symptoms and Quality of Life Among Postmenopausal Women in the United States and Western Europe.
DiBonaventura M; Luo X; Moffatt M; Bushmakin AG; Kumar M; Bobula J
J Womens Health (Larchmt); 2015 Sep; 24(9):713-22. PubMed ID: 26199981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
